Pfizer
Anneka Norgren has over 20 years of experience in operations and corporate affairs, currently serving as Chief of Staff and Senior Director of Operations at Pfizer since November 2004. In addition, Anneka holds the position of Director for Corporate Responsibility and Executive Director of The Pfizer Foundation. Earlier career experience includes serving as a Program Coordinator at Funders Concerned About AIDS from September 2000 to October 2003 and as a Project Manager at Huntington Associates from February 1997 to July 1999. Anneka Norgren earned a Master of Public Administration in Nonprofit Management from the Robert F. Wagner School at New York University and a Bachelor of Arts in Political Science from Barnard College, Columbia University.
This person is not in any teams
Pfizer
606 followers
Pfizer Inc. is a research-based, global biopharmaceutical company. They apply science and their global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. They work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Pfizer collaborates with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. Pfizer was founded in 1942. Most of Pfizer’s revenues come from the manufacture and sale of biopharmaceutical products. They believe that their medicines and vaccines provide significant value for healthcare providers and patients, through improved treatment of diseases, improvements in health, wellness and productivity as well as by reducing other healthcare costs, such as emergency room or hospitalization. Pfizer is committed to fulfilling their purpose: Breakthroughs that change patients’ lives. Their purpose fuels everything they do and reflects both their passion for science and commitment to patients. Pfizer’s growth strategy is driven by five “Bold Moves” that help them deliver breakthroughs for patients and create value for shareholders and other stakeholders: 1. Unleash the power of our people; 2. Deliver first-in-class science; 3. Transform our go-to-market model; 4. Win the digital race in pharma; and 5. Lead the conversation.